21.961 articles found

Surgical treatment of Parkinson's disease: ablation, stimulation and transplantation.

Marks WJ.

Expert Rev Neurother · 2001-11-01

DOI: 10.1002/1615-9861(200102)1:2<239::aid-prot239>3.0.co;2-kPMID: 19811035

Stem cells as therapeutics for neurodegenerative disorders?

Mattson MP.

Expert Rev Neurother · 2001-11-01

DOI: 10.1586/14737175.1.2.267PMID: 19811037

Methods for therapy of neurodegenerative disease of the brain

TUSZYNSKI MARK H.

· 2001-10-26

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances.

Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S.

Annu Rev Public Health · 2001-10-25

DOI: 10.1146/annurev.publhealth.23.100901.140525PMID: 11910061

Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.

Ramig LO, Sapir S, Countryman S, Pawlas AA, O'Brien C, Hoehn M, Thompson LL.

J Neurol Neurosurg Psychiatry · 2001-10-01

DOI: 10.1136/jnnp.71.4.493PMID: 11561033

Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia.

Bustillo JR, Lauriello J, Rowland LM, Jung RE, Petropoulos H, Hart BL, Blanchard J, Keith SJ, Brooks WM.

Psychiatry Res · 2001-10-01

DOI: 10.1016/s0925-4927(01)00102-0PMID: 11566430

Gene therapy for Parkinson's disease: recent achievements and remaining challenges.

Castro MG, David A, Hurtado-Lorenzo A, Suwelack D, Millan E, Verakis T, Xiong WD, Yuan XP, Lowenstein PR.

Histol Histopathol · 2001-10-01

DOI: 10.14670/hh-16.1225PMID: 11642742

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.

Marin C, Jiménez A, Bonastre M, Vila M, Agid Y, Hirsch EC, Tolosa E.

Synapse · 2001-10-01

DOI: 10.1002/syn.1097PMID: 11668589

[Treatment of Parkinson's disease with COMT inhibitors].

Shabtai H, Korczyn A.

Harefuah · 2001-10-01

PMID: 11681127

CT-guided unilateral thalamotomy with macroelectrode mapping for the treatment of Parkinson's disease.

Valálik I, Sági S, Solymosi D, Julow J.

Acta Neurochir (Wien) · 2001-10-01

DOI: 10.1007/s007010170007PMID: 11685609

Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.

Westin JE, Andersson M, Lundblad M, Cenci MA.

Eur J Neurosci · 2001-10-01

DOI: 10.1046/j.0953-816x.2001.01743.xPMID: 11683909

Sustained delivery of GDNF: towards a treatment for Parkinson's disease.

Zurn AD, Widmer HR, Aebischer P.

Brain Res Brain Res Rev · 2001-10-01

DOI: 10.1016/s0165-0173(01)00098-4PMID: 11690619